Leerink Partners upgraded shares of Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) from a market perform rating to an ...

Equities researchers at Leerink Partnrs decreased their Q3 2025 EPS estimates for shares of Envista in a research report ...

An investment banker who left Goldman Sachs & Co. for Leerink Partners LLC advanced part of her lawsuit saying she was denied promised bonuses and deferred grant awards worth millions of dollars.

The company built a digital platform for medical professionals that helps carry out telehealth appointments with patients, ...

Q4 2024. Management View. CEO Mark Tarr emphasized strong financial performance in Q4 2024, with revenue increasing ...

If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...

We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to ...

Officer of Insmed Inc. (NASDAQ:INSM), recently sold a significant amount of company stock amid the company's impressive 178% surge over the past year. According to a recent SEC filing, Flammer sold a ...

Read about the latest analyst upgrades and downgrades on major stocks like AMD, Skyworks, Palantir, Nike, and more in this weekly market update.

Mark Tarr; President, Chief Executive Officer, Director; Encompass Health Corp Douglas Coltharp; Chief Financial Officer, Executive Vice President; Encompass Health Corp Today's conference call is ...